Abstract
AIM—To measure drug adherence in children with mild asthma receiving long term prophylactic treatment. METHODS—Double blind randomised placebo controlled trial. Patients received inhaled budesonide 100 µg or 200 µg daily, or placebo for 27 months. All participants were asked to inhale medication or placebo from two different Turbuhalers (morning and evening) during the study. A total of 122 children (80 boys, 42 girls) aged 7-16 years with mild asthma (mean FEV1 103.7% of predicted) were included in the trial. Drug adherence was assessed by counting the number of remaining doses in the inhaler when study medication was returned at six month intervals. RESULTS—A statistically significant and continuing decrease in measured drug adherence was found from three to nine months and then to 27 months, reaching mean values of 40.6% and 46.9% for inhaled morning and evening medication respectively. Drug adherence declined more rapidly in the placebo group (compared to active treatment); this difference became significant after two years of treatment. Children aged 9 years or less had better drug adherence during the entire study period, but the difference was only significant for the first three months of the study. Measured drug adherence was significantly higher for evening medication compared to morning medication for all study intervals after nine months. CONCLUSION—Measured drug adherence diminishes significantly when treating children with mild asthma in a long term trial. This emphasises the importance of monitoring compliance in clinical trials.
Full Text
The Full Text of this article is available as a PDF (119.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asthma: a follow up statement from an international paediatric asthma consensus group. Arch Dis Child. 1992 Feb;67(2):240–248. doi: 10.1136/adc.67.2.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coutts J. A., Gibson N. A., Paton J. Y. Measuring compliance with inhaled medication in asthma. Arch Dis Child. 1992 Mar;67(3):332–333. doi: 10.1136/adc.67.3.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jónasson G., Carlsen K. H., Sødal A., Jonasson C., Mowinckel P. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Eur Respir J. 1999 Jul;14(1):150–154. doi: 10.1034/j.1399-3003.1999.14a25.x. [DOI] [PubMed] [Google Scholar]
- Milgrom H., Bender B., Ackerson L., Bowry P., Smith B., Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol. 1996 Dec;98(6 Pt 1):1051–1057. doi: 10.1016/s0091-6749(96)80190-4. [DOI] [PubMed] [Google Scholar]
- Rand C. S., Wise R. A., Nides M., Simmons M. S., Bleecker E. R., Kusek J. W., Li V. C., Tashkin D. P. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992 Dec;146(6):1559–1564. doi: 10.1164/ajrccm/146.6.1559. [DOI] [PubMed] [Google Scholar]
- Reiser J., Warner J. O. The value of participating in an asthma trial. Lancet. 1985 Jan 26;1(8422):206–207. doi: 10.1016/s0140-6736(85)92037-9. [DOI] [PubMed] [Google Scholar]
- Vignola A. M., Chanez P., Campbell A. M., Souques F., Lebel B., Enander I., Bousquet J. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med. 1998 Feb;157(2):403–409. doi: 10.1164/ajrccm.157.2.96-08040. [DOI] [PubMed] [Google Scholar]
- Warner J. O., Naspitz C. K. Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group. Pediatr Pulmonol. 1998 Jan;25(1):1–17. doi: 10.1002/(sici)1099-0496(199801)25:1<1::aid-ppul1>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]